Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (184)	1/20/1999 10:59:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 613

subthread CNSI re posts 43, mainly 132, and Scott's query in post 184 CNSI, Cambridge NeuroScience, my largest position, trades right near book value. The deal they did with Bayer means that they are free not ever to worry about finances for the entire development of rhGGF2, their lead candidate for a number of CNS diseases, but especially for MS for remylenation. The Yahoo thread is very good, and I would suggest read a dozen posts starting with #1291...beware all, this is an investment, not a trading opportunity and I expect to hold most of my shares five years. Of course, in this case, I have bought extra shares at the current price, 3/4, so that if it pops back up to around $1 1/2, I can take some quick gains too...I like to trade part of my investment, keeps me watching the thing and my interest in the issue etc. Most of the reason the stock is down right now can probably be attributed to the price itself, and the possibility of de-listing, but with the Bayer deal, I hope that does not happen. If it does...like I said, cnsi is an investment and I wont get a pop any time soon--rhGGF2 is not even in clinical trials yet as far as I know...the query on recap.com just shows a bunch of L's for lead, in like eight CNS diseases. Actually, if cnsi gets a new partner for something else, say Cerestat again, then it will pop on that, but who can say. I see on the yahoo cnsi thread that the fellow who has some sort of a friendly relationship with the ceo is back...and he has a series of posts there too now after phoning the company recently. I never like to call...but I did email the company and when I get a response I'll compare my notes to his...I am astonished that a private investor could have the sort of access that "YukonHusky" seems to have...but I cant find any reason to disbeleive the fellow either. --MIke